Published in Clin J Am Soc Nephrol on August 26, 2010
Influence of race, ethnicity and socioeconomic status on kidney disease. Nat Rev Nephrol (2012) 1.67
The role of race and poverty on steps to kidney transplantation in the Southeastern United States. Am J Transplant (2012) 1.66
Long-term quality of life after liver donation in the adult to adult living donor liver transplantation cohort study (A2ALL). J Hepatol (2014) 1.56
The association of community health indicators with outcomes for kidney transplant recipients in the United States. Arch Surg (2012) 1.53
Patient attitudes toward mobile phone-based health monitoring: questionnaire study among kidney transplant recipients. J Med Internet Res (2013) 1.46
Dialysis facility and network factors associated with low kidney transplantation rates among United States dialysis facilities. Am J Transplant (2014) 1.27
Modifiable patient characteristics and racial disparities in evaluation completion and living donor transplant. Clin J Am Soc Nephrol (2013) 1.12
Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States. Clin J Am Soc Nephrol (2013) 1.05
Living Donor Kidney Transplantation: Overcoming Disparities in Live Kidney Donation in the US--Recommendations from a Consensus Conference. Clin J Am Soc Nephrol (2015) 0.99
Your Path to Transplant: a randomized controlled trial of a tailored computer education intervention to increase living donor kidney transplant. BMC Nephrol (2014) 0.92
Prominent impact of community risk factors on kidney transplant candidate processes and outcomes. Am J Transplant (2013) 0.91
Assessing Transplant Education Practices in Dialysis Centers: Comparing Educator Reported and Medicare Data. Clin J Am Soc Nephrol (2015) 0.87
Socioeconomic inequalities in quality of care and outcomes among patients with acute coronary syndrome in the modern era of drug eluting stents. J Am Heart Assoc (2014) 0.84
Geographic determinants of access to pediatric deceased donor kidney transplantation. J Am Soc Nephrol (2014) 0.80
Kidney transplantation and the intensity of poverty in the contiguous United States. Transplantation (2014) 0.80
Health literacy of living kidney donors and kidney transplant recipients. Transplantation (2014) 0.79
Socioeconomic deprivation and barriers to live-donor kidney transplantation: a qualitative study of deceased-donor kidney transplant recipients. BMJ Open (2016) 0.78
Influence of Socio-Economic Inequalities on Access to Renal Transplantation and Survival of Patients with End-Stage Renal Disease. PLoS One (2016) 0.77
Comorbidities and kidney transplant evaluation in the elderly. Am J Nephrol (2013) 0.77
The impact of socioeconomic status and geographic remoteness on access to pre-emptive kidney transplantation and transplant outcomes among children. Pediatr Nephrol (2015) 0.77
Has the Department of Veterans Affairs found a way to avoid racial disparities in the evaluation process for kidney transplantation? Transplantation (2016) 0.75
Are There Inequities in Treatment of End-Stage Renal Disease in Sweden? A Longitudinal Register-Based Study on Socioeconomic Status-Related Access to Kidney Transplantation. Int J Environ Res Public Health (2017) 0.75
Regional differences in renal replacement therapy in northern Norway 2000-2012. Int J Circumpolar Health (2015) 0.75
What factors explain the association between socioeconomic deprivation and reduced likelihood of live-donor kidney transplantation? A questionnaire-based pilot case-control study. BMJ Open (2016) 0.75
Barriers to living donor kidney transplantation in the United Kingdom: a national observational study. Nephrol Dial Transplant (2017) 0.75
Mortality and Graft Loss Attributable to Readmission following Kidney Transplantation: Immediate and Long-Term Risk. Transplantation (2016) 0.75
Barriers to cadaveric renal transplantation among blacks, women, and the poor. JAMA (1998) 5.10
Racial disparities in access to renal transplantation--clinically appropriate or due to underuse or overuse? N Engl J Med (2000) 4.67
Effect of changing the priority for HLA matching on the rates and outcomes of kidney transplantation in minority groups. N Engl J Med (2004) 3.96
Geographic access to health care for rural Medicare beneficiaries. J Rural Health (2006) 3.04
Neighborhood poverty and racial disparities in kidney transplant waitlisting. J Am Soc Nephrol (2009) 2.45
Regionalization of high-risk surgery and implications for patient travel times. JAMA (2003) 2.41
Rates of completion of the medical evaluation for renal transplantation. Am J Kidney Dis (2005) 2.22
Risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites. San Antonio Heart Study. Am J Epidemiol (1990) 2.03
Race and socioeconomic factors influencing early placement on the kidney transplant waiting list. J Am Soc Nephrol (1998) 2.02
Insurance type and minority status associated with large disparities in prelisting dialysis among candidates for kidney transplantation. Clin J Am Soc Nephrol (2008) 1.98
Disparities in the utilization of live donor renal transplantation. Am J Transplant (2009) 1.87
Geographic variability in access to primary kidney transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.77
Geographic differences in event rates by model for end-stage liver disease score. Am J Transplant (2006) 1.62
A systematic review of patient and health system characteristics associated with late referral in chronic kidney disease. BMC Nephrol (2008) 1.56
Kidney and pancreas transplantation in the United States, 1999-2008: the changing face of living donation. Am J Transplant (2010) 1.55
Geographic differences in access to transplantation in the United States. Transplantation (2003) 1.42
Differences in attitudes toward organ donation among African Americans and whites in the United States. J Natl Med Assoc (2001) 1.33
Role of socioeconomic status in kidney transplant outcome. Clin J Am Soc Nephrol (2006) 1.32
Sociodemographic differences in early access to liver transplantation services. Am J Transplant (2009) 1.30
Access to liver transplantation in the MELD era: role of ethnicity and insurance. Dig Dis Sci (2008) 1.21
Cardiovascular health in Puerto Ricans compared to other population groups in the United States. Ethn Dis (1991) 1.19
Delayed referral to a nephrologist: outcomes among patients who survive at least one year on dialysis. Med J Aust (2002) 1.18
Impact of geographic location on access to liver transplantation among ethnic minorities. Transplantation (2008) 1.12
Differences in health-related quality of life and treatment preferences among black and white patients with end-stage renal disease. Qual Life Res (2004) 0.94
Regional and racial disparities in the use of live non-directed kidney donors. Am J Transplant (2008) 0.85
Gestational hypertension and preeclampsia in living kidney donors. N Engl J Med (2014) 7.25
Desensitization in HLA-incompatible kidney recipients and survival. N Engl J Med (2011) 6.72
Association of race and age with survival among patients undergoing dialysis. JAMA (2011) 5.82
Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg (2010) 5.72
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. N Engl J Med (2015) 5.03
Lifetime incidence of CKD stages 3-5 in the United States. Am J Kidney Dis (2013) 3.82
Racial variation in medical outcomes among living kidney donors. N Engl J Med (2010) 3.60
Early mobilization of patients hospitalized with community-acquired pneumonia. Chest (2003) 2.85
Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant (2005) 2.76
Sarcopenia and mortality after liver transplantation. J Am Coll Surg (2010) 2.75
Domino paired kidney donation: a strategy to make best use of live non-directed donation. Lancet (2006) 2.38
Liver transplantation cost in the model for end-stage liver disease era: looking beyond the transplant admission. Liver Transpl (2009) 2.38
Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients. Transplantation (2014) 2.26
Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant (2003) 2.22
Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant (2005) 2.19
Sensitivity of billing claims for cardiovascular disease events among kidney transplant recipients. Clin J Am Soc Nephrol (2009) 2.17
Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation. JAMA (2005) 2.15
Estimates of early death, acute liver failure, and long-term mortality among live liver donors. Gastroenterology (2011) 2.07
Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis. J Am Geriatr Soc (2013) 2.06
Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol (2004) 1.93
Candidacy for kidney transplantation of older adults. J Am Geriatr Soc (2012) 1.85
Center-level factors and racial disparities in living donor kidney transplantation. Am J Kidney Dis (2012) 1.82
Racial disparities in the management of hospitalized patients with cirrhosis and complications of portal hypertension: a national study. Hepatology (2007) 1.82
Kidney paired donation and optimizing the use of live donor organs. JAMA (2005) 1.82
A nonsimultaneous, extended, altruistic-donor chain. N Engl J Med (2009) 1.81
The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation. Liver Transpl (2011) 1.79
Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients. Transplantation (2012) 1.78
Caroli's disease and outcomes after liver transplantation. Liver Transpl (2008) 1.78
Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients. J Am Soc Nephrol (2003) 1.77
Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review. Transplantation (2009) 1.75
Utilization and outcomes of kidney paired donation in the United States. Transplantation (2008) 1.74
ABO incompatible renal transplantation: a paradigm ready for broad implementation. Transplantation (2009) 1.71
Health insurance considerations for adolescent transplant recipients as they transition to adulthood. Pediatr Transplant (2007) 1.68
Patient attitudes toward CDC high infectious risk donor kidney transplantation: inferences from focus groups. Clin Transplant (2011) 1.64
Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation. Transplantation (2014) 1.62
Live donor champion: finding live kidney donors by separating the advocate from the patient. Transplantation (2012) 1.60
Acute dialysis risk in living kidney donors. Nephrol Dial Transplant (2012) 1.60
Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users. J Infect Dis (2010) 1.58
Cumulative incidence of cancer after solid organ transplantation. Cancer (2013) 1.58
Assessment of racial disparities in chronic kidney disease stage 3 and 4 care in the department of defense health system. Clin J Am Soc Nephrol (2008) 1.56
Outcomes of ABO-incompatible kidney transplantation in the United States. Transplantation (2012) 1.55
Trends in kidney transplant outcomes in older adults. J Am Geriatr Soc (2014) 1.53
Incidence, predictors and associated outcomes of rhabdomyolysis after kidney transplantation. Nephrol Dial Transplant (2009) 1.52
Pregnancy outcomes of liver transplant recipients: a systematic review and meta-analysis. Liver Transpl (2012) 1.52
Trends in post-liver transplant survival in patients with hepatitis C between 1991 and 2001 in the United States. Liver Transpl (2007) 1.51
Race, Relationship and Renal Diagnoses After Living Kidney Donation. Transplantation (2015) 1.45
Lifetime cost-effectiveness of calcineurin inhibitor withdrawal after de novo renal transplantation. J Am Soc Nephrol (2008) 1.45
Living kidney donors ages 70 and older: recipient and donor outcomes. Clin J Am Soc Nephrol (2011) 1.45
Transplant certification and quality assessment: time to take the front line? Prog Transplant (2013) 1.43
Cost Implications of New National Allocation Policy for Deceased Donor Kidneys in the United States. Transplantation (2016) 1.42
Effect of eliminating priority points for HLA-B matching on racial disparities in kidney transplant rates. Am J Kidney Dis (2011) 1.41
Impact of broader sharing on the transport time for deceased donor livers. Liver Transpl (2014) 1.41
The impact of nonidentical ABO deceased donor kidney transplant on kidney utilization. Am J Kidney Dis (2010) 1.39
Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective usage of renal allografts. Transplantation (2008) 1.35
Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant. Am J Transplant (2004) 1.33
A comparison of populations served by kidney paired donation and list paired donation. Am J Transplant (2005) 1.32
Frailty and delayed graft function in kidney transplant recipients. Arch Surg (2012) 1.30
Living unrelated renal transplantation: a good match for the pediatric candidate? J Pediatr Surg (2013) 1.30
Resource utilization in patients hospitalized with heart failure: insights from a contemporary national hospital database. Am Heart J (2008) 1.27
Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation. Transplantation (2008) 1.27
Kidney transplantation in the elderly. Semin Nephrol (2009) 1.27
Nationwide increase in hospitalizations and hepatitis C among inpatients with cirrhosis and sequelae of portal hypertension. Clin Gastroenterol Hepatol (2007) 1.25
Vascular disease, ESRD, and death: interpreting competing risk analyses. Clin J Am Soc Nephrol (2012) 1.23
Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donors. Transplantation (2014) 1.22
Liver sharing and organ procurement organization performance. Liver Transpl (2015) 1.21
Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clin Exp Nephrol (2008) 1.21
Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality. Am J Kidney Dis (2008) 1.20
Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation (2006) 1.14
The implications of acute rejection for allograft survival in contemporary U.S. kidney transplantation. Transplantation (2012) 1.14
Mycophenolate mofetil dose reductions and discontinuations after gastrointestinal complications are associated with renal transplant graft failure. Transplantation (2006) 1.13
Agreement of immunosuppression regimens described in Medicare pharmacy claims with the Organ Procurement and Transplantation Network survey. J Am Soc Nephrol (2006) 1.13
Robust Models Support Redistricting Liver Allocation to Reduce Geographic Disparity. Transplantation (2015) 1.12
Understanding surgical decision making in early hepatocellular carcinoma. J Clin Oncol (2011) 1.12
National trends over 25 years in pediatric kidney transplant outcomes. Pediatrics (2014) 1.11
Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation. Clin J Am Soc Nephrol (2005) 1.11
Trends in the timing of pre-emptive kidney transplantation. J Am Soc Nephrol (2011) 1.10
Renal function and healthcare costs in patients with polycystic kidney disease. Clin J Am Soc Nephrol (2010) 1.10
Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol (2012) 1.09
De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications. Am J Kidney Dis (2005) 1.09